Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Manual Medicine vs Corticosteroid Infiltration for Acromioclavicular Arthropathy
NCT03951480Terminated
- Sponsor
- CHD Vendée
- Start
- Nov 2020
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by CHD Vendée. Primary endpoint: Efficacy on pain of manual medical care versus infiltrative care at 3 months. Started Nov 2020; status: terminated.
Beyond the preview
Go deeper on NCT03951480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03951480.